Prohibited Stimulants in Dietary Supplements After Enforcement Action by the US Food and Drug Administration
نویسندگان
چکیده
منابع مشابه
The Effects of Stimulants on Invertebrates: Caffeine and Dietary Supplements
Caffeine and dietary supplements have been shown to play a role in the regulation and circulation of blood. If taken in excessive amounts, they may cause damage to the circulatory system or heart. To test the effects for myself, I administered both caffeine and dietary supplements on water organisms, specifically daphnia. The results for caffeine turned out as expected and further proved the ef...
متن کاملThe US Food and Drug Administration and probiotics: regulatory categorization.
Probiotics are living microorganisms that, when consumed, have the potential to confer a beneficial health effect. Unfortunately for purveyors of probiotic products, the system of regulation delineated in the Food, Drug, and Cosmetic Act is anything but "one size fits all." How a probiotic product is used or is intended to be used will govern the regulatory category or categories that the US Fo...
متن کاملCrisis deepens at the US Food and Drug Administration.
BMJ VOLUME 329 4 DECEMBER 2004 bmj.com The US Food and Drug Administration, rocked by controversy in recent months, has now admitted that a senior management official secretly contacted a whistleblower group. That official attempted to discredit Dr David Graham, the FDA’s scientist who criticised the agency during US Senate hearings, saying that the FDA failed to protect the public when it appr...
متن کاملTHE U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES ( FOOD AND DRUG ADMINISTRATION Dietary Supplements Containing > Ephedrine Alkaloids; Reopening
متن کامل
US Food and Drug Administration Perspectives on Clinical Mass Spectrometry.
Mass spectrometry-based in vitro diagnostic devices that measure proteins and peptides are underutilized in clinical practice, and none has been cleared or approved by the Food and Drug Administration (FDA) for marketing or for use in clinical trials. One way to increase their utilization is through enhanced interactions between the FDA and the clinical mass spectrometry community to improve th...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: JAMA Internal Medicine
سال: 2018
ISSN: 2168-6106
DOI: 10.1001/jamainternmed.2018.4846